Should We Edit the Genetic Essence of Life?
By Margaret Somerville,
The Globe and Mail
| 06. 08. 2015
Untitled Document
The human germline is the genetic essence of human life. It’s the genes passed on from generation to generation that have evolved over billions of years since the advent of life on Earth which have resulted in each of us. We can now alter an embryo’s germline genes and all descendants of that embryo will inherit those alterations. Is that ethical?
The human germline’s been described as “the common heritage of humankind that must be held in trust for future generations.” Until very recently there was widespread agreement that intentional interference with it was unethical and should not be allowed. The UNESCO Universal Declaration on the Human Genome and Human Rights (1997) characterized germline interventions as “practices that could be contrary to human dignity;” the Council of Europe’s European Convention on Human Rights and Biomedicine (Oviedo Convention, 1997) bans interventions on the human genome that could be inherited, that is, on the human germline; the Canadian Assisted Human Reproduction Act 2004 prohibits “alter[ing] the genome of a cell of a human being or in-vitro embryo such that the...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...